NUTRACEUTIX INC
10QSB, EX-27, 2000-11-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NUTRACEUTIX INC, 10QSB, EX-11.1, 2000-11-14
Next: INTER ACT ELECTRONIC MARKETING INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AND STATEMENTS OF OPERATIONS FOUND ON THE FORM 10-QSB FOR THE NINE MONTH
PERIOD ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         217,718
<SECURITIES>                                         0
<RECEIVABLES>                                1,221,891
<ALLOWANCES>                                   (5,312)
<INVENTORY>                                  1,607,940
<CURRENT-ASSETS>                             3,192,162
<PP&E>                                       3,143,444
<DEPRECIATION>                               1,415,869
<TOTAL-ASSETS>                               5,659,039
<CURRENT-LIABILITIES>                        2,661,780
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        17,762
<OTHER-SE>                                   1,977,370
<TOTAL-LIABILITY-AND-EQUITY>                 5,659,039
<SALES>                                      6,232,536
<TOTAL-REVENUES>                             6,232,536
<CGS>                                        4,619,820
<TOTAL-COSTS>                                1,844,266
<OTHER-EXPENSES>                             (556,643)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             226,199
<INCOME-PRETAX>                                 98,894
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             98,894
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    98,894
<EPS-BASIC>                                      0.006
<EPS-DILUTED>                                    0.005


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission